Constellation Pharmaceuticals, Inc.
P300/CBP HAT INHIBITORS
Last updated:
Abstract:
Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with histone acetyltransferase (HAT). ##STR00001##
Status:
Application
Type:
Utility
Filling date:
15 Feb 2019
Issue date:
4 Mar 2021